About Veracyte

Veracyte(NASDAQ: VCYT) is pioneering the field of molecular cytology, offering genomic solutions that resolve diagnostic ambiguity and enable physicians to make more informed treatment decisions at an early stage in patient care. By improving preoperative diagnostic accuracy, the company aims to help patients avoid unnecessary invasive procedures while – more... 

Claim this company page
Headquarters
South San Francisco California, United States
Revenue
$38.2 Million
Employees
51 to 200
Industry
Links
Veracyte website